How to use the speech recognition tool?
NCT02544217
A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Clinical Trial With KH176
A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Clinical Trial With KH176.
Type: Interventional
Status of the trial: Completed
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 2015-05-01
- Closing Date: 2015-09-01
Criteria
Children: No
Adults: Yes
Funder Type: industry
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Neuro-Ophthalmology Rare Diseases (WG2)